In addition, recent studies indicate that the IDH1 wildtype enzyme may be overexpressed in over 60% of glioblastomas [114,115], suggesting that PET tracers with limited selectivity for mutated isoforms could give false positive results when used to assess the IDH status in these patients. The gene discussed is IDH1; the disease is glioblastoma.